mhurhangee/patent-ind-claim-en huggingface dataset:
A polymerizable composition comprising: (a) at least one first (meth)acrylate functional monomer represented by the following Formula (I), wherein, L 1 is selected from, a multivalent optionally substituted hydrocarbyl group optionally interrupted with at least one of -C(O)-, -S-, -O-, and combinations thereof, and a divalent linking group represented by the following Formula (A), wherein Y is O or S, L 2 is independently for each n a divalent optionally substituted hydrocarbyl group optionally interrupted with at least one of -O- and -S-, R 1 is independently selected for each n from hydrogen and methyl, and n is from 2 to 6; (b) a polymerization moderator; and (c) optionally, at least one monoethylenically unsaturated monomer; wherein said polymerization moderator comprises at least one of 1-isopropyl-4-methyl-1,4-cyclohexadiene, 1-isopropyl-4-methyl-1,3-cyclohexadiene, 1-methyl-4-(propan-2-ylidene)cyclohex-1-ene, and 2,6-dimethyl-2,4,6-octatriene. (a) at least one first (meth)acrylate functional monomer represented by the following Formula (I), wherein, L 1 is selected from, a multivalent optionally substituted hydrocarbyl group optionally interrupted with at least one of -C(O)-, -S-, -O-, and combinations thereof, and a divalent linking group represented by the following Formula (A), wherein Y is O or S, L 2 is independently for each n a divalent optionally substituted hydrocarbyl group optionally interrupted with at least one of -O- and -S-, R 1 is independently selected for each n from hydrogen and methyl, and n is from 2 to 6; L 2 is independently for each n a divalent optionally substituted hydrocarbyl group optionally interrupted with at least one of -O- and -S-, R 1 is independently selected for each n from hydrogen and methyl, and n is from 2 to 6; (b) a polymerization moderator; and (c) optionally, at least one monoethylenically unsaturated monomer; wherein said polymerization moderator comprises at least one of 1-isopropyl-4-methyl-1,4-cyclohexadiene, 1-isopropyl-4-methyl-1,3-cyclohexadiene, 1-methyl-4-(propan-2-ylidene)cyclohex-1-ene, and 2,6-dimethyl-2,4,6-octatriene.
A method comprising: providing a powder composition including at least one ultrafine, spherical thermoplastic polymer powder having a glass transition temperature Tg of at least 150 degrees C; and powder bed fusing the powder composition to form a three-dimensional article; wherein the powder composition comprises between 50 to 100 weight percent of the at least one ultrafine, spherical thermoplastic polymer powder, based on the weight of polymeric materials in the powder; and wherein each ultrafine, spherical thermoplastic polymer powder is monomodal and has a mean particle size of about 10 to about 75 microns and the amount of powder particles smaller than 10 microns is less than 2 percent by volume; wherein the thermoplastic polymer powder is chosen from polyetherimides, polysulfones, polyarylsulfones and combinations thereof.
Article having a main body composed of a polymeric material having elastic properties, characterized in that all or part of the article surface has been provided with at least one flock , where the article is the damping element of a bearing, of a bushing or of a multilayered spring, cone spring, and where fibres or textile fibres used for the flock intrinsically offer adequate fire protection or intrinsically have adequate flame retardancy.
A ubiquitin C (UBC) antagonist for use in a method of treating cancer in a patient, the method comprising: (a) identifying a patient having cancer with (i) a reduced mRNA expression level of a ubiquitin B (UBB) gene product or (ii) a ratio of a mRNA expression level of a UBC gene product to a mRNA expression level of a UBB gene product that is greater than 1.25; and (b) administering the UBC antagonist to the patient. (a) identifying a patient having cancer with (i) a reduced mRNA expression level of a ubiquitin B (UBB) gene product or (ii) a ratio of a mRNA expression level of a UBC gene product to a mRNA expression level of a UBB gene product that is greater than 1.25; and (i) a reduced mRNA expression level of a ubiquitin B (UBB) gene product or (ii) a ratio of a mRNA expression level of a UBC gene product to a mRNA expression level of a UBB gene product that is greater than 1.25; and (b) administering the UBC antagonist to the patient.
A control method of a microwave oven circuit, wherein the microwave oven circuit comprises a magnetron and an inverter circuit for driving the magnetron to work, and the control method comprises: when the inverter circuit needs to be started, detecting a zero crossing point of an electric supply signal for supplying power to the microwave oven circuit; when the electric supply signal is detected to reach the zero crossing point, controlling the inverter circuit to be powered on; when the power-on time length of the inverter circuit reaches a first predetermined time length, inputting a first power signal with a frequency lower than a target frequency to the inverter circuit ; detecting the current in the magnetron ; and when the current in the magnetron reaches a predetermined current value, inputting a second power signal with a frequency equal to the target frequency to the inverter circuit . when the inverter circuit needs to be started, detecting a zero crossing point of an electric supply signal for supplying power to the microwave oven circuit; when the electric supply signal is detected to reach the zero crossing point, controlling the inverter circuit to be powered on; when the power-on time length of the inverter circuit reaches a first predetermined time length, inputting a first power signal with a frequency lower than a target frequency to the inverter circuit ; detecting the current in the magnetron ; and when the current in the magnetron reaches a predetermined current value, inputting a second power signal with a frequency equal to the target frequency to the inverter circuit .
A method of creating a three dimensional object from reactive components that form a thermoset product using extruded thermoset printing, comprising: providing a first reactive component and a second reactive component that are effective to form a thermoset product having a predetermined layer resolution during the method, wherein the first reactive component comprises a polyol and/or amine prepolymer, a fast reactant, and a slow reactant, wherein the first reactive component comprises 1% to 10% fast reactant and 1% to 75% slow reactant, and wherein the second reactive component comprises an isocyanate prepolymer that comprises a monomeric isocyanate; introducing the first reactive component and the second reactive component into a mixing chamber where mixing occurs to form a mixture, wherein the first reactive component and the second reactive component have a residence time in the mixing chamber effective to form a partially reacted thermoset product in the mixing chamber and result in the predetermined layer resolution upon exiting the mixing chamber, and wherein the first reactive component and the second reactive component have a residence time in the mixing chamber insufficient to completely react; extruding the partially reacted thermoset product out of the mixing chamber through an extrusion nozzle and onto a substrate; and moving the extrusion nozzle and/or the substrate to form a 3D object having a predetermined shape resolution. providing a first reactive component and a second reactive component that are effective to form a thermoset product having a predetermined layer resolution during the method, wherein the first reactive component comprises a polyol and/or amine prepolymer, a fast reactant, and a slow reactant, wherein the first reactive component comprises 1% to 10% fast reactant and 1% to 75% slow reactant, and wherein the second reactive component comprises an isocyanate prepolymer that comprises a monomeric isocyanate; introducing the first reactive component and the second reactive component into a mixing chamber where mixing occurs to form a mixture, wherein the first reactive component and the second reactive component have a residence time in the mixing chamber effective to form a partially reacted thermoset product in the mixing chamber and result in the predetermined layer resolution upon exiting the mixing chamber, and wherein the first reactive component and the second reactive component have a residence time in the mixing chamber insufficient to completely react; extruding the partially reacted thermoset product out of the mixing chamber through an extrusion nozzle and onto a substrate; and moving the extrusion nozzle and/or the substrate to form a 3D object having a predetermined shape resolution.
Valve-actuating device comprising a manual operating element and a valve which can be actuated by means of the manual operating element , wherein a control element is operatively connected to the manual operating element , wherein the valve can be actuated by a distal end of the control element , and a compensating device is arranged in operative connection between the control element and the manual operating element , which compensating device has a plunger , which is movably guided in a receptacle , and allows a relative movement of the manual operating element with respect to the control element , and wherein a restoring element is present which counters the relative movement with a restoring force, characterized in that the plunger is formed on a proximal end of the control element and in that the receptacle of the compensating device is arranged fixedly on the manual operating element .
Device (10; 50; 100; 200; 300; 400; 500; 700; 800) for generating and controlling a magnetic field intensity, comprising - a first material (24; 611a) which, upon physical excitation, generates luminescence and/or photocurrent, wherein the luminescence or photocurrent exhibits a resonance point with respect to a magnetic field at at least one magnetic flux density, - means (28; 616, 618) for generating the physical excitation, - means (12, 16, 18, 20, 22; 52, 54; 102, 104, 106, 108; 304, 306; 502; 604, 606, 608) for generating a magnetic field, wherein the first material (24; 611a) is exposed to the generated magnetic field, wherein the intensity of the magnetic field is adjustable, and - means (34; 76, 78, 80; 632) for measuring luminescence or photocurrent with a detection signal (36; 82, 84, 86; 636) which represents the intensity of the detected luminescence signal or photocurrent signal, wherein the device is characterized by - control means (38; 88; 640) which are adapted to provide a control signal (40; 90; 112; 642) for controlling the means (12, 16, 18, 20, 22; 52, 54; 102, 104, 106, 108; 304, 306; 502; 602, 604, 606, 608) for generating a magnetic field and for controlling the magnetic field intensity as a function of the detection signal (36; 82, 84, 86; 636) so that the detection signal (36; 82, 84, 86; 636) takes a resonance extreme value. - a first material (24; 611a) which, upon physical excitation, generates luminescence and/or photocurrent, wherein the luminescence or photocurrent exhibits a resonance point with respect to a magnetic field at at least one magnetic flux density, - means (28; 616, 618) for generating the physical excitation, - means (12, 16, 18, 20, 22; 52, 54; 102, 104, 106, 108; 304, 306; 502; 604, 606, 608) for generating a magnetic field, wherein the first material (24; 611a) is exposed to the generated magnetic field, wherein the intensity of the magnetic field is adjustable, and - means (34; 76, 78, 80; 632) for measuring luminescence or photocurrent with a detection signal (36; 82, 84, 86; 636) which represents the intensity of the detected luminescence signal or photocurrent signal, wherein the device is characterized by - control means (38; 88; 640) which are adapted to provide a control signal (40; 90; 112; 642) for controlling the means (12, 16, 18, 20, 22; 52, 54; 102, 104, 106, 108; 304, 306; 502; 602, 604, 606, 608) for generating a magnetic field and for controlling the magnetic field intensity as a function of the detection signal (36; 82, 84, 86; 636) so that the detection signal (36; 82, 84, 86; 636) takes a resonance extreme value.
A Secondary Cell, SCell, state indication method for a network side device , comprising: configuring state transition indication information, the state transition indication information being used to indicate an SCell state transition between two of an activated state, a deactivated state and a third state ; and transmitting the state transition indication information to a User Equipment, UE , wherein the state transition indication information comprises a Logical Channel Identity, LCID, and a first MAC CE of N bits, where N is a positive integer; the first MAC CE comprises a field of M SCell sequence bits C i , where M is a positive integer smaller than or equal to N, and i is an integer smaller than or equal to M; a value of the LCID and a value of C i in the field of M SCell sequence bits C i are used to indicate the state transition of the SCell corresponding to C i between two of the activated state, the deactivated state and the third state, wherein when the value of the LCID is a first predetermined value, the state of the SCell corresponding to C i having a second predetermined value is indicated to be transited into the third state; when the value of the LCID is a third predetermined value, the state of the SCell corresponding to C i having a fourth predetermined value is indicated to leave the third state, wherein the state transition indication information further comprises a second MAC CE; the second MAC CE is used to indicate the SCell state transition from the third state into the activated state or the deactivated state. configuring state transition indication information, the state transition indication information being used to indicate an SCell state transition between two of an activated state, a deactivated state and a third state ; and transmitting the state transition indication information to a User Equipment, UE , wherein the state transition indication information comprises a Logical Channel Identity, LCID, and a first MAC CE of N bits, where N is a positive integer; the first MAC CE comprises a field of M SCell sequence bits C i , where M is a positive integer smaller than or equal to N, and i is an integer smaller than or equal to M; a value of the LCID and a value of C i in the field of M SCell sequence bits C i are used to indicate the state transition of the SCell corresponding to C i between two of the activated state, the deactivated state and the third state, wherein when the value of the LCID is a first predetermined value, the state of the SCell corresponding to C i having a second predetermined value is indicated to be transited into the third state; when the value of the LCID is a third predetermined value, the state of the SCell corresponding to C i having a fourth predetermined value is indicated to leave the third state, wherein the state transition indication information further comprises a second MAC CE; the second MAC CE is used to indicate the SCell state transition from the third state into the activated state or the deactivated state.
Fastener to a mechanical mounting, with an electrical measuring device or a part of an electrical measuring device, whereby the fastener has a shaft with a thread and an electrical conductor positioned in a screw thread of the thread , the conductor being electrically isolated from the shaft .
A microfluidics device for use in a clinical chemistry instrument, the microfluidics device comprising: at least one compartment capable of receiving a sample suspected of containing a target hydrophobic analyte, wherein the at least one compartment comprises: a pretreatment reagent comprising at least one enzyme that digests lipoprotein; and at least one assay reagent capable of detecting a hydrophobic analyte for determining a concentration of target hydrophobic analyte present in the sample; wherein the target hydrophobic analyte is selected from the group consisting of vitamin D, tacrolimus, sirolimus, everolimus, estrogen, estrone, estradiol, estriol, alfatradiol, cyclosporine, ethinylestradiol, esterified estrogens, moxestrol, qunestrol, progestins, progesterone, androgens, testosterone, dihydroteestosterione (DHT), dehydroepiandrosterone (DHEA), DHEA sulfate, androstenendione aldosterone, cortisol, catecholamine, 25-hydroxy Vitamin D2, 25-hydroxy Vitamin D3, 1,25-dihydroxy Vitamin D2, and 1,25-dihydroxy Vitamin D3. a pretreatment reagent comprising at least one enzyme that digests lipoprotein; and at least one assay reagent capable of detecting a hydrophobic analyte for determining a concentration of target hydrophobic analyte present in the sample; wherein the target hydrophobic analyte is selected from the group consisting of vitamin D, tacrolimus, sirolimus, everolimus, estrogen, estrone, estradiol, estriol, alfatradiol, cyclosporine, ethinylestradiol, esterified estrogens, moxestrol, qunestrol, progestins, progesterone, androgens, testosterone, dihydroteestosterione (DHT), dehydroepiandrosterone (DHEA), DHEA sulfate, androstenendione aldosterone, cortisol, catecholamine, 25-hydroxy Vitamin D2, 25-hydroxy Vitamin D3, 1,25-dihydroxy Vitamin D2, and 1,25-dihydroxy Vitamin D3.
An apparatus for an injection needle that enables reuse of a single-use injection needle for multiple injection uses for a same user, the apparatus comprising: a needle cover with a first stack as a wicking medium to absorb excess fluid droplets, a second stack as a disinfecting agent to disinfect the injection needle , and a third stack as a lubricating agent to lubricate the injection needle that are positioned inside the needle cover ; a guide mechanism that guides the needle cover onto the injection needle ; wherein the needle cover sanitizes, disinfects and lubricates a single-use injection needle for reuse when the needle is moved inside the needle cover and positioned therein for temporary storage; wherein the agents are stacked in a medium on top of each other in heights for different needle lengths. a needle cover with a first stack as a wicking medium to absorb excess fluid droplets, a second stack as a disinfecting agent to disinfect the injection needle , and a third stack as a lubricating agent to lubricate the injection needle that are positioned inside the needle cover ; a guide mechanism that guides the needle cover onto the injection needle ; wherein the needle cover sanitizes, disinfects and lubricates a single-use injection needle for reuse when the needle is moved inside the needle cover and positioned therein for temporary storage; wherein the agents are stacked in a medium on top of each other in heights for different needle lengths.
A vehicle control method in which, when a drive source stop condition is established while a vehicle is traveling, a sailing stop control is executed in which a drive source of the vehicle is stopped, an engaging element provided between the drive source and a drive wheel is released, and the vehicle travels under inertia, the vehicle control method comprising: acquiring (S10) information on a status of a road on which the host vehicle will travel; predicting (S20) whether there is a section on a route where the sailing stop control can be executed based on the information; upon predicting that the section is present where the sailing stop control can be executed, estimating (S30) a power shortage amount, which is a shortage in an amount of power during the sailing stop control, based on the information; and charging a battery with power required to cover the power shortage amount prior to starting the sailing stop control, wherein the power shortage amount is estimated as being larger when autonomous driving is performed in the section where the sailing stop control is executed as compared to when driver-enabled driving is performed in the section and the information includes route information, map information acquired by a navigation system, a travel history of the vehicle, and other information acquired through road-to-vehicle communication and/or vehicle-to-vehicle communication. acquiring (S10) information on a status of a road on which the host vehicle will travel; predicting (S20) whether there is a section on a route where the sailing stop control can be executed based on the information; upon predicting that the section is present where the sailing stop control can be executed, estimating (S30) a power shortage amount, which is a shortage in an amount of power during the sailing stop control, based on the information; and charging a battery with power required to cover the power shortage amount prior to starting the sailing stop control, wherein the power shortage amount is estimated as being larger when autonomous driving is performed in the section where the sailing stop control is executed as compared to when driver-enabled driving is performed in the section and the information includes route information, map information acquired by a navigation system, a travel history of the vehicle, and other information acquired through road-to-vehicle communication and/or vehicle-to-vehicle communication.
An apparatus comprising: a depositing mechanism configured to perform an overcoat depositing operation, the depositing mechanism comprising a plurality of print head arrays each being arrangeable in a deposit position to deposit an overcoat layer onto a substrate and a service position to enable servicing to be performed; and an array controller configured to cause at least one print head array of the plurality of print head arrays to be moved periodically from the deposit position to the service position according to a predefined servicing sequence during an ongoing overcoat depositing operation performed by the depositing mechanism , wherein the predefined servicing sequence has a predefined service interval between servicing operations for each print head array of the plurality of print head arrays , and characterized in that the array controller is configured to determine the predefined service interval by at least one characteristic of the overcoat layer. a depositing mechanism configured to perform an overcoat depositing operation, the depositing mechanism comprising a plurality of print head arrays each being arrangeable in a deposit position to deposit an overcoat layer onto a substrate and a service position to enable servicing to be performed; and an array controller configured to cause at least one print head array of the plurality of print head arrays to be moved periodically from the deposit position to the service position according to a predefined servicing sequence during an ongoing overcoat depositing operation performed by the depositing mechanism , wherein the predefined servicing sequence has a predefined service interval between servicing operations for each print head array of the plurality of print head arrays , and characterized in that the array controller is configured to determine the predefined service interval by at least one characteristic of the overcoat layer.